30/09/2020 - 11:48 Corporate news Gimv is 40: Wij doen wat veel fondsen niet durven' Uit Trends van 24/09/2020 Weiterlesen
22/10/2020 - 17:55 Portfolio Gimv and founder sell Eurocept Homecare - active in ’Hospital-at-home‘ services and complex wound care - to Mediq Weiterlesen
19/10/2020 - 09:18 Portfolio Topas Therapeutics raises EUR 22 Million in Series B Financing and appoints new CEO Weiterlesen
01/10/2020 - 07:30 Portfolio Gimv invests in French company Biolam for further roll-out as regional challenger in medical diagnostics laboratories Weiterlesen
30/09/2020 - 12:07 Portfolio 2020 09 29 - Repositionnement plus écologique pour le groupe AgroBiothers Weiterlesen
15/09/2020 - 11:19 Portfolio ImCheck Announces Investment by BB Pureos Bioventures to Close Series B Fundraising with Total of €54 million ($64 million) Weiterlesen
20/08/2020 - 10:55 Portfolio Melijoe and Gimv join forces with The Babyshop Group to strengthen global leadership in high-end children's fashion Weiterlesen
23/07/2020 - 17:45 Finanziell Outcome of the optional dividend for the financial year 2019/2020: 63.4% of the dividend rights on the financial year 2019/2020 are distributed in the form of new ordinary shares, resulting in a capital increase of EUR 28.2 million. Weiterlesen
02/07/2020 - 14:04 Portfolio Grandeco shifts up a gear thanks to the strategic acquisition of Holden Decor Limited, one of UK's leading wallcovering companies Weiterlesen
29/06/2020 - 17:50 Portfolio Gimv, D2E and founders sell logistics service provider Contraload to Tosca, an American player in reusable packaging and supply chain solutions Weiterlesen
29/06/2020 - 17:45 Portfolio Gimv beteiligt sich an Televic, einem Entwickler und Hersteller von High-Tech-Kommunikationslösungen Weiterlesen
24/06/2020 - 17:45 Finanziell Report of the Annual, Special and Extraordinary General Shareholders’ Meeting - Approval of a gross dividend of EUR 2.50 per share in the form of an optional dividend Weiterlesen
24/06/2020 - 07:30 Finanziell Gimv - Modalités du dividende optionnel - Apport du droit au dividende net en échange de la souscription d'une nouvelle action à 45,50 euros ou 26 droits au dividende relatifs à l’exercice 2019/2020 Weiterlesen
11/06/2020 - 10:05 Portfolio 2020 06 19 - GTX announces FDA Breakthrough Device Designation Weiterlesen
04/06/2020 - 07:30 Portfolio Spineart, the fast-growing spinal devices company, welcomes EGS Beteiligungen AG which invests CHF 50 million of growth equity Weiterlesen
26/05/2020 - 13:47 Portfolio 2020 05 26 - Biotalys awarded EUR 1.6 million VLAIO research grant Weiterlesen
20/05/2020 - 17:00 Convocation of the annual, special and extraordinary general meeting of Gimv on June 24th, 2020 Weiterlesen
20/05/2020 - 07:00 Finanziell Beteiligungsgesellschaft Gimv: Belastbar dank starkem Portfolio und robuster Bilanz Weiterlesen
06/05/2020 - 09:30 Portfolio Biotalys’ first biocontrol proves consistent with high efficacy in global fruit and vegetables field trials Weiterlesen
28/04/2020 - 16:33 Portfolio Companies that keep on going during the crisis. Even now Coolworld is 24/7/365 ready for you. Weiterlesen
28/04/2020 - 15:20 Portfolio First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma Weiterlesen
